» Articles » PMID: 24832207

DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour

Overview
Journal PLoS One
Date 2014 May 17
PMID 24832207
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

In melanoma, the presence of promoter related hypermethylation has previously been reported, however, no methylation-based distinction has been drawn among the diverse melanoma subtypes. Here, we investigated DNA methylation changes associated with melanoma progression and links between methylation patterns and other types of somatic alterations, including the most frequent mutations and DNA copy number changes. Our results revealed that the methylome, presenting in early stage samples and associated with the BRAF(V600E) mutation, gradually decreased in the medium and late stages of the disease. An inverse relationship among the other predefined groups and promoter methylation was also revealed except for histologic subtype, whereas the more aggressive, nodular subtype melanomas exhibited hypermethylation as well. The Breslow thickness, which is a continuous variable, allowed for the most precise insight into how promoter methylation decreases from stage to stage. Integrating our methylation results with a high-throughput copy number alteration dataset, local correlations were detected in the MYB and EYA4 genes. With regard to the effects of DNA hypermethylation on melanoma patients' survival, correcting for clinical cofounders, only the KIT gene was associated with a lower overall survival rate. In this study, we demonstrate the strong influence of promoter localized DNA methylation changes on melanoma initiation and show how hypermethylation decreases in melanomas associated with less favourable clinical outcomes. Furthermore, we establish the methylation pattern as part of an integrated apparatus of somatic DNA alterations.

Citing Articles

5-Methylcytosine immunohistochemistry for predicting cutaneous melanoma prognosis.

Meevassana J, Varophas S, Prabsattru P, Kamolratanakul S, Ruangritchankul K, Kitkumthorn N Sci Rep. 2024; 14(1):7554.

PMID: 38555324 PMC: 10981665. DOI: 10.1038/s41598-024-58011-z.


HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy.

Cristofani R, Piccolella M, Montagnani Marelli M, Tedesco B, Poletti A, Moretti R Cell Death Dis. 2022; 13(11):973.

PMID: 36400750 PMC: 9674643. DOI: 10.1038/s41419-022-05365-9.


Current understanding of epigenetics role in melanoma treatment and resistance.

Karami Fath M, Azargoonjahromi A, Soofi A, Almasi F, Hosseinzadeh S, Khalili S Cancer Cell Int. 2022; 22(1):313.

PMID: 36224606 PMC: 9555085. DOI: 10.1186/s12935-022-02738-0.


Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.

Rius F, Papaiz D, Azevedo H, Ayub A, Pessoa D, Oliveira T Clin Epigenetics. 2022; 14(1):68.

PMID: 35606887 PMC: 9128240. DOI: 10.1186/s13148-022-01291-x.


Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis.

Yates J, Boeva V Brief Bioinform. 2022; 23(2).

PMID: 35134107 PMC: 8921629. DOI: 10.1093/bib/bbab610.


References
1.
Bae J, Kim J, Kang G . Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype. Histol Histopathol. 2013; 28(5):585-95. DOI: 10.14670/HH-28.585. View

2.
Gershenwald J, Soong S, Balch C . 2010 TNM staging system for cutaneous melanoma...and beyond. Ann Surg Oncol. 2010; 17(6):1475-7. DOI: 10.1245/s10434-010-0986-3. View

3.
Chu S, Feng D, Ma Y, Zhang H, Zhu Z, Li Z . Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma. J Transl Med. 2011; 9:156. PMC: 3184631. DOI: 10.1186/1479-5876-9-156. View

4.
Lazar V, Ecsedi S, Vizkeleti L, Rakosy Z, Boross G, Szappanos B . Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization. Melanoma Res. 2012; 22(3):202-14. DOI: 10.1097/CMR.0b013e328352dbc8. View

5.
Acquaviva L, Szekvolgyi L, Dichtl B, Dichtl B, de La Roche Saint Andre C, Nicolas A . The COMPASS subunit Spp1 links histone methylation to initiation of meiotic recombination. Science. 2012; 339(6116):215-8. DOI: 10.1126/science.1225739. View